Patients from the T2D-IDF group seem to have more structured and unified shapes of glucose and insulin secretion profiles during OGTT than ones with T2D-ADA; nevertheless, the group size is too small for any far-reaching conclusions. This evidence concerns the gene INS and type 2 diabetes mellitus.